Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (851-860 of 903) with videos related to

Pageof 91
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2024
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individualsLuigi Lorenzini, Lyduine E Collij, Niccoló Tesi, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery DatasetJan Homann, Tim Osburg, Olena Ohlei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 4, 2019
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R Morgan, Samuel Touchard, Claire Leckey, et al.
The Lancet. Neurology|September 19, 2019
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling studyIngrid S van Maurik, Stephanie J Vos, Isabelle Bos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2014
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's diseaseFrank Jessen, Rebecca E Amariglio, Martin van Boxtel, et al.
The Lancet Regional Health. Europe|March 10, 2023
Dementia prevention in memory clinics: recommendations from the European task force for brain health servicesGiovanni B Frisoni, Daniele Altomare, Federica Ribaldi, et al.
Translational Psychiatry|September 3, 2021
Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansionsLianne M Reus, Iris E Jansen, Merel O Mol, et al.
Brain Communications|October 23, 2024
Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's diseaseLisa Vermunt, Courtney L Sutphen, Ellen Dicks, et al.
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Pageof 91

Showing results (851-860 of 903) with videos related to

Sort By:
Pageof 91
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 29, 2024
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individualsLuigi Lorenzini, Lyduine E Collij, Niccoló Tesi, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery DatasetJan Homann, Tim Osburg, Olena Ohlei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 4, 2019
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R Morgan, Samuel Touchard, Claire Leckey, et al.
The Lancet. Neurology|September 19, 2019
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling studyIngrid S van Maurik, Stephanie J Vos, Isabelle Bos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2014
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's diseaseFrank Jessen, Rebecca E Amariglio, Martin van Boxtel, et al.
The Lancet Regional Health. Europe|March 10, 2023
Dementia prevention in memory clinics: recommendations from the European task force for brain health servicesGiovanni B Frisoni, Daniele Altomare, Federica Ribaldi, et al.
Translational Psychiatry|September 3, 2021
Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansionsLianne M Reus, Iris E Jansen, Merel O Mol, et al.
Brain Communications|October 23, 2024
Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's diseaseLisa Vermunt, Courtney L Sutphen, Ellen Dicks, et al.
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Pageof 91